Exclusive investor-only Longevity conference announced

A group of Swiss investors and entrepreneurs targets the global Longevity investor community with an exclusive approach.

Longevity is set to be one of the largest investment opportunities of the near future; with that in mind, the Longevity Investors Conference is curating a programme of top-class speakers from all over the world, including David Sinclair, Aubrey de Grey and Emil Kendziorra, with new speakers being announced shortly.

Longevity.Technology: Following on from the success of our Longevity Investing programme at Longevity2020, Longevity.Technology is proud to be the official media partner of The Longevity Investors Conference.

Set to provide relevant insights into the subject, expert education, investment opportunities and networking – the online conference is targeting private and institutional investors from (U)HNWIs, Family Offices, VCs, Private Equity Funds, Private Banks and Asset Managers. As well as a focus on the most relevant Longevity investors and fund activity, sub-topics include life-extension and cryonics.


“The longevity industry is highly attractive for investors. We see a lack of education and information for investors and want to change this …”



Co-organiser Dr Tobias Reichmuth is excited by the plan: “The longevity industry is highly attractive for investors. We see a lack of education and information for investors and want to change this. While there are scientific-oriented conferences, a professional and global investor focused longevity conference was missing so far.”

First Longevity

Marc P Bernegger, co-organiser (main image), adds “The recent progress in radical life extension is very impressive and creates unique and massive investment opportunities.”

The event takes-place on 1 October 2020, however, the team is already planning 2021, and next year’s conference will be held at the prestigious Suvretta House in St Moritz in Switzerland.

Stay-tuned for updates as we get closer to the content and speakers over the coming months.

Applications open via this link.

First Longevity
Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

Latest articles

Neurotech2020 – a clear head for neurotech, research and investment

Tomorrow's dreams today ... well, next week – it's Neurotech2020. Neurotech2020 – the digital congress for neurotechnology innovation and growth – is coming to (your...

Biotech Elevian announces $15m equity financing

The anti-aging company looks to the clinic with Prime Movers Lab leading the round. Massachusets-based Elevian announced this week that it had closed $15 million equity...

eGenesis advances xenotransplantation research

Reducing waiting lists and treating diabetes – eGenesis progresses xeno without the paradox. Recently we covered eGenesis' progress in its xenotransplantation research, as it attempts...

Review: WHOOP fitness tracker

We trialled this beautifully-understated fitness/sleep tracking device to see if it would make us whoop with joy or holler for something else.   GO LONG    GO...